• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

biotech deals

scissor cutting rope
Biotech

AbbVie to end Calico collab, lay off scientists: Stat

The changes come as the Chicago-area pharma pivots away from small molecules in favor of injectables and genetic medicines, according to Stat.
Gabrielle Masson Nov 13, 2025 3:59pm
masquerade mask

Third Arc Bio teams up with Adagene to create T-cell engagers

Nov 13, 2025 10:45am
cancer target detection radiopharma radio

Lyell signs deal for phase 1-stage colorectal cancer CAR-T

Nov 10, 2025 9:45am
Robot hands with a pieces of the puzzle

Lilly continues AI push, inking $100M-plus deal with Insilico

Nov 10, 2025 9:00am
Goal disorientation and lack of vision

Lilly pens $1.2B pact with Sanegene to target metabolic RNA meds

Nov 10, 2025 4:05am
Colorful portrait of women in STEM outside Organon facility

Organon divests Jada System, sends 100 employees to Laborie

Nov 7, 2025 9:05am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings